Biliary Tract Cancer: Current Roles of Radiation Therapy

Abstract Biliary tract cancers, encompassing gallbladder cancer, intrahepatic cholangiocarcinoma (IHCC), and extrahepatic cholangiocarcinoma (EHCC), are rare malignancies with limited prospective studies guiding their management. Radiation therapy has evolved significantly over the years, advancing from conventional fractionated approaches to innovative modalities such as stereotactic body radiation therapy (SBRT) and hypofractionated radiation therapy. This review explores the role of radiation therapy in biliary tract cancers, with a particular focus on IHCC and EHCC, highlighting its historical evolution, current applications, and future directions. For IHCC, external beam radiation therapy has demonstrated benefits in retrospective analyses, with modern conformal techniques such as intensity-modulated radiation therapy and volumetric modulated arc therapy enabling safe dose escalation and improved local control. SBRT and hypofractionated radiation therapy offer promising alternatives for unresectable or recurrent IHCC, with high local control rates and manageable toxicity profiles reported in retrospective and early-phase prospective studies. Despite these advancements, the need for robust phase III comparative trials remains critical. In EHCC, radiation therapy plays a pivotal role in adjuvant and definitive settings. Additionally, radiation therapy is increasingly utilized as part of neoadjuvant protocols for liver transplantation candidates with unresectable hilar cholangiocarcinoma, improving outcomes when combined with strict selection criteria and modern systemic therapies. This review underscores the importance of a multidisciplinary approach to the management of biliary tract cancers, integrating radiation therapy advancements with systemic and surgical therapies. Future research should focus on personalized treatment strategies, leveraging novel technologies and biomarker-driven approaches to optimize outcomes for this challenging patient population.

Institutions

Publication Details

Journal
Digestive Disease Interventions
Published
2025-03-05
DOI
https://doi.org/10.1055/s-0045-1805052
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biliary Tract Cancer: Current Roles of Radiation Therapy

Digestive Disease Interventions
Cholangiocarcinoma and Gallbladder Cancer Studies
article

Biliary Tract Cancer: Current Roles of Radiation Therapy

article en

Abstract

Abstract Biliary tract cancers, encompassing gallbladder cancer, intrahepatic cholangiocarcinoma (IHCC), and extrahepatic cholangiocarcinoma (EHCC), are rare malignancies with limited prospective studies guiding their management. Radiation therapy has evolved significantly over the years, advancing from conventional fractionated approaches to innovative modalities such as stereotactic body radiation therapy (SBRT) and hypofractionated radiation therapy. This review explores the role of radiation therapy in biliary tract cancers, with a particular focus on IHCC and EHCC, highlighting its historical evolution, current applications, and future directions. For IHCC, external beam radiation therapy has demonstrated benefits in retrospective analyses, with modern conformal techniques such as intensity-modulated radiation therapy and volumetric modulated arc therapy enabling safe dose escalation and improved local control. SBRT and hypofractionated radiation therapy offer promising alternatives for unresectable or recurrent IHCC, with high local control rates and manageable toxicity profiles reported in retrospective and early-phase prospective studies. Despite these advancements, the need for robust phase III comparative trials remains critical. In EHCC, radiation therapy plays a pivotal role in adjuvant and definitive settings. Additionally, radiation therapy is increasingly utilized as part of neoadjuvant protocols for liver transplantation candidates with unresectable hilar cholangiocarcinoma, improving outcomes when combined with strict selection criteria and modern systemic therapies. This review underscores the importance of a multidisciplinary approach to the management of biliary tract cancers, integrating radiation therapy advancements with systemic and surgical therapies. Future research should focus on personalized treatment strategies, leveraging novel technologies and biomarker-driven approaches to optimize outcomes for this challenging patient population.

Digestive Disease Interventions
University of Michigan (US), Michigan Medicine (US), Michigan Center for Translational Pathology (US)
Good health and well-being
Openalex Percentile: Top 38%
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Biliary Tract Cancer: Current Roles of Radiation Therapy · Digestive Disease Interventions (2025) | TGRS Research Map | TGRS